BioSpace News Archive

ASIA announced that it had entered an agreement with Swysh Inc., an Alberta company focused on the conduct of specific cannabinoid-based research and development activities and that owns proprietary technology and related intellectual property aimed at providing the basis for creation of topical and systemic treatments for a variety of external and internal conditions and ailments, including a number of anti-viral and preventative health-care applications.

Mymetics Corporation announced that its subsidiary, Mymetics BV, has signed a Research Collaboration Agreement with Baylor College of Medicine and Texas Children’s Center for Vaccine Development for evaluating their rationally designed recombinant protein-based SARS-CoV and SARS-CoV-2 antigens and combining them with Mymetics’ virosomes for the development of a safe and effective Covid-19 vaccine.

ADMA Biologics, Inc., announced it has commenced the collection of convalescent plasma through its wholly-owned subsidiary, ADMA BioCenters Georgia Inc., from individuals who have recovered from COVID-19.

DENTSPLY SIRONA Inc., The Dental Solutions Company™, announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share of common stock, an indicated annual rate of $0.40 per share.

Novel TKI compound with dual selective targeting of mutant forms of EGFR and BTK More than 600 patients have been treated with the compound across studies, with over 200 patients in the completed registrational trial SAN DIEGO, May 21, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) and ACEA Therapeutics, Inc. (“ACEA”) have entered into a binding term sheet for an exclusive license to ACEA’s Abivertinib across all indications for all territories outside of C

Advancements in medical research has played an integral role in the growth of the global ubiquitin enzymes market.

Cryopreservation equipment market has been gaining traction due to its widening applications.

High blood pressure is one of the most common cases across the globe. Blood pressure measurement is vital for the identification of the intensity of the pressure.

Demand for disinfection cap is mainly driving by growing prevalence of hospital acquired infections and strict regulation for safe injection practice.

The demand within the global retrievable stents market is expected to increase at a stellar pace.